德必集團(300947.SZ):實控人、長興乾潤及間接持股的董事、高管延長限售股鎖定期
格隆匯7月30日丨德必集團(300947.SZ)公佈,公司股票於2021年2月10日上市,自2021年7月2日至2021年7月29日,公司股票連續20個交易日的收盤價均低於發行價51.47元/股(對應實施2020 年年度利潤分配及資本公積轉增股本方案後的除權除息價格為33.65元/股),觸發上述股份鎖定期延長承諾的履行條件。
公司控股股東、實際控制人、長興乾潤以及間接持有公司股份的董事、高級管理人員持有限售流通股的情況及此次延長限售股鎖定期的情況如下表所示:

上述延長承諾鎖定期的股份未解除限售前,因公司送紅股、轉增股本、配股 等原因而增加的股份亦將遵守相關承諾。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.